Healthcare Supplies company Medplus Health Services announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Revenue: Rs 56,249 million Increase by 23.4% vs FY23, 14.3% private label (+0.6% vs FY23) Gross Margin: Rs 12,332 million, 21.9% gross margin 585 Store Net Additions 670 gross additions and 333 net additions beyond Tier-One 4,407 stores as on 31-Mar-24 20.5% revenue growth for stores opened more than 12 months vs. FY23 9.2% Store Level EBITDA margin Operating EBITDA: Rs 1,748 million 3.1% Operating EBITDA margin Pharmacy Operating EBITDA Rs 1,882 million Operating Cash Flow: Rs 1,437 million 82.2% OCF/ Operating EBITDA closing cash balance: Rs 1,702 million FY24 Financial Highlights: Revenue: Rs 14,905 million, Rs 2,375 million increase over Q4FY23, 19.0% YoY, and Rs 490 million increase over Q3FY24. 3.4% QoQ 1.1% increase in private label over Q4FY23 Gross Margin: Rs 3,366 million, 22.6% gross margin (0.5% QoQ) 174 Store Net Additions and 199 gross additions 100 net store additions beyond Tier-One 4,407 stores as on 31-Mar-24 11.7% revenue growth for stores opened for more than 12 months over Q4FY23 10.3% Store Level EBITDA margin 52.2% Store Level Operating ROCE Pharmacy Operating EBITDA: Rs 593 million 4.0% Operating EBITDA margin in Pharmacy (increased by 40 bps QoQ) Company Operating EBITDA: Rs 581 million Operating Cash Flow: Rs 406 million 69.8% OCF/ Operating EBITDA closing cash balance: Rs 1,702 million Result PDF